Effects of PPAR gamma ligands on TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells.
about
Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transitionPPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesisPuerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition.PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis.Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.Advanced glycation end products of bovine serum albumin-induced endothelial-to-mesenchymal transition in cultured human and monkey endothelial cells via protein kinase B signaling cascades.PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosisFibrosis in systemic sclerosis: common and unique pathobiology.Transforming growth factor beta 1 induced endothelin-1 release is peroxisome proliferator-activated receptor gamma dependent in A549 cellsEmerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases.Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis.PPARγ Ligands Regulate Noncontractile and Contractile Functions of Airway Smooth Muscle: Implications for Asthma Therapy.PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines.New players for advanced prostate cancer and the rationalisation of insulin-sensitising medicationUnderstanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy.The Role of PPAR Gamma in Systemic Sclerosis.The molecular pathogenesis of morphoea: from genetics to future treatment targets.Evodiamine might inhibit TGF-beta1-induced epithelial-mesenchymal transition in NRK52E cells via Smad and PPAR-gamma pathway.Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-γ in human proximal tubule epithelial cells.Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface.Effects of doxycycline on production of growth factors and matrix metalloproteinases in pulmonary fibrosis.Pioglitazone inhibits TGFβ induced keratocyte transformation to myofibroblast and extracellular matrix production.Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies.Localization of ανβ6 integrin-TGF-β1/Smad3, mTOR and PPARγ in experimental colorectal fibrosis.Cellular and molecular mechanisms of intestinal fibrosis.Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells.Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis.
P2860
Q30498249-B0DF5C10-2F92-45BF-9E86-DD993F1982BAQ33745028-F0F71BBA-37ED-4764-8BE5-B0A1AC97B75FQ33790719-A0086D91-B378-4D1D-A6D6-088EF99C519CQ33799182-13D84D02-A170-4BBC-A201-B6F1B812D52BQ34321160-A76ABED0-5EA8-4593-A48E-B6994352C727Q34410712-09F98410-EC5C-47BA-BD89-795D71621C19Q35711530-47DC7D9A-6D5B-4133-8111-1D28D36681BAQ35954579-635BE356-7942-47D7-B285-66BFAAB57D24Q36012572-3941C9B3-B39A-4B9B-A570-48411795309FQ36049930-3D2C2E2E-AED7-4C2A-AB12-A4E073F8EE8AQ36063833-E775EA81-AAC1-469F-BB51-500E9BBC96F5Q36093802-E945A3AD-2B7E-4084-882A-6DA968C213C2Q36200396-42F39C9E-12C4-470D-B50E-A643874CF276Q36605155-126EEB2B-63E8-464E-83E2-72C3FDACEFC4Q36734036-9B8251DF-0CB9-4209-9555-BF6018144AB3Q37638268-C1D56070-C816-42DB-9D3D-140BD4D2D1F1Q37721063-11EE1A0C-09CC-4E7B-9351-79EAD20EBABCQ37847515-B342B5B5-A44C-4985-9547-5C5395CD2B7DQ38524619-00904C82-61D3-4EAE-A5CC-24BB07118250Q38828584-8D8E1782-BFC1-4F37-B3B0-4F22105A1150Q39017725-4DB5EAAA-060F-4F1A-B042-EF0DB607A0CCQ39285206-E24A979B-172A-40D5-BBEF-3FFA71DF65D9Q39401444-46FE8B52-A6C5-4450-88E1-F23E73906182Q39556672-9D736851-F4B9-40C2-9FB3-F0210316613AQ39624471-198C433B-DA90-43AF-A0AD-1B2253E73A1FQ41681579-73DC787E-BB29-4016-AA9F-FDEDF56B4AE6Q41879637-C13080F8-801C-45BB-81D3-DE542444CFBAQ42252132-2838C63B-F8BA-4E1C-840B-CEAD4BBA4CACQ42760591-862F874C-2655-4E5D-9C3E-1084417AD6DCQ47109594-3B23EF3A-FBB0-4D3F-8ACD-C4D7BD8E80F6
P2860
Effects of PPAR gamma ligands on TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effects of PPAR gamma ligands ...... in alveolar epithelial cells.
@ast
Effects of PPAR gamma ligands ...... in alveolar epithelial cells.
@en
type
label
Effects of PPAR gamma ligands ...... in alveolar epithelial cells.
@ast
Effects of PPAR gamma ligands ...... in alveolar epithelial cells.
@en
prefLabel
Effects of PPAR gamma ligands ...... in alveolar epithelial cells.
@ast
Effects of PPAR gamma ligands ...... in alveolar epithelial cells.
@en
P2093
P2860
P356
P1433
P1476
Effects of PPAR gamma ligands ...... n in alveolar epithelial cells
@en
P2093
Hayat Dagher
Jane E Bourke
Xiahui Tan
P2860
P2888
P356
10.1186/1465-9921-11-21
P577
2010-02-23T00:00:00Z
P5875
P6179
1050961291